KRAS G12C inhibitor 13 |
| Catalog No.GC36397 |
L'inhibiteur de KRAS G12C 13 est un inhibiteur de KRAS G12C extrait du brevet WO2018143315A1, composé 30.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2241719-75-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
KRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30[1]. KRas G12C
[1]. KURAMOTO, Kazuyuki, et al. Quinazoline compound. WO2018143315A1.
Review for KRAS G12C inhibitor 13
Average Rating: 5 (Based on Reviews and 33 reference(s) in Google Scholar.)
Review for KRAS G12C inhibitor 13
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *